SCHEMBL19347152

SCHEMBL19347152

c1ccc(C(c2ccccc2)N2CCCCCNCCC2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.70
MEN1 O00255 1/20 0.70
CYP2C9 P11712 7/20 0.58
CYP2C19 P33261 5/20 0.58
USP2 O75604 4/20 0.58
CYP2D6 P10635 8/20 0.56
CYP3A4 P08684 7/20 0.56
CYP1A2 P05177 6/20 0.56
TP53 P04637 1/20 0.56
ALOX15 P16050 1/20 0.56
OPRD1 P41143 7/20 0.55
OPRM1 P35372 2/20 0.53
OPRK1 P41145 1/20 0.53
KCNH2 Q12809 5/20 0.53
KCNA5 P22460 4/20 0.53
KCNE1 P15382 1/20 0.53
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8479321 0.91 MEN1 (0.85) KMT2AMEN1CYP2C9CYP2C19USP2
Hydrochloric Acid SCHEMBL11455379 0.89 MEN1 (0.82) KMT2AMEN1CYP2C9CYP2C19USP2
SCHEMBL5267415 0.87 CYP2D6 (0.68) KMT2AMEN1CYP2C9CYP2C19USP2
Hydrochloric Acid SCHEMBL31327366 0.85 CYP2D6 (0.65) KMT2AMEN1CYP2C9CYP2C19USP2
SCHEMBL2054235 0.84 CYP2D6 (0.67) KMT2AMEN1CYP2C9CYP2C19USP2
SCHEMBL2794662 0.83 MEN1 (1.00) KMT2AMEN1CYP2C9CYP2C19USP2
SCHEMBL219432 0.83 MEN1 (1.00) KMT2AMEN1CYP2C9CYP2C19USP2
Hydrochloric Acid SCHEMBL16107427 0.82 CYP2D6 (0.64) KMT2AMEN1CYP2C9CYP2C19USP2
SCHEMBL5363117 0.82 CYP2D6 (0.76) KMT2AMEN1CYP2C9CYP2C19USP2
Hydrochloric Acid SCHEMBL7006476 0.81 MEN1 (0.96) KMT2AMEN1CYP2C9CYP2C19USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260185-A1 2-[BIS(4-FLUOROPHENYL)METHYL]-2,7-DIAZASPIRO[4.5]DECAN-10-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN DOPAMINE-ACTIVE-TRANSPORTER (DAT) PROTEIN FOR THE TREATMENT OF E.G. ATTENTION DEFICIT DISORDER (ADD) CHRONOS THERAPEUTICS LIMITED (GB) 2017-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170260185-A1 2-[BIS(4-FLUOROPHENYL)METHYL]-2,7-DIAZASPIRO[4.5]DECAN-10-ONE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF THE HUMAN DOPAMINE-ACTIVE-TRANSPORTER (DAT) PROTEIN FOR THE TREATMENT OF E.G. ATTENTION DEFICIT DISORDER (ADD) SLC6A3, SLC6A4, SLC6A2 KMT2A 644/4885MEN1 3418/4885CYP2C9 1131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.